Characterization of 8-(N-methylisopropyl)amino-N 6-(5′-endohydroxy-endonorbornyl)-9-methyladenine (WRC-0571), a highly potent and selective, non-xanthine antagonist of A1 adenosine receptors

Journal of Pharmacology and Experimental Therapeutics

Volumn 276, Issue 2, 1996, Pages 490-499

  Martin, P L ^a   Wysocki Jr , R J ^a   Barrett, R J ^a   May, J M ^b   Linden, J ^c  

^a ADERIS Pharmaceuticals Inc   (United States)

^b Alanex ^*  (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 N (5 HYDROXYNORBORNAN 2 YL) 8 (N ISOPROPYL N METHYLAMINO) 9 METHYLADENINE; 9 METHYL 6 N (2 NORBORNYL)ADENINE; ADENINE; ADENOSINE RECEPTOR; DRUG DERIVATIVE; NORBORNANE DERIVATIVE;

ANIMAL; ARTICLE; CATTLE; DRUG ANTAGONISM; DRUG EFFECT; GUINEA PIG; HEART RATE; HUMAN; IN VITRO STUDY; MALE; RAT; SPRAGUE DAWLEY RAT; STRUCTURE ACTIVITY RELATION;

ADENINE; ANIMALS; CATTLE; GUINEA PIGS; HEART RATE; HUMANS; MALE; NORBORNANES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P1; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0030078102     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. 1 receptors in vivo. Eur. J. Pharmacol 216: 9-16, 1992
2. 1 receptor antagonist. J. Pharmacol. Exp. Ther. 265: 227-236, 1993.
3. 2 receptor selectivity of adenosine receptor agonists in vivo. J. Pharmacol. Exp. Ther. 268: 1166-1173, 1994.
4. BELARDINELLI, L., LINDEN, J. AND BERNE, R. M.: The cardiac effects of adenosine. Prog. Cardiovasc. Dis. 32: 73-97, 1989.
5. BRUNS, R. F.: Adenosine receptor activation in human fibroblasts nucleoside agonists and antagonists. Can. J. Physiol. Pharmacol. 58: 673-691, 1980.
6. BRUNS, R. F., DALY, J. W. AND SNYDER, S. H.: Adenosine receptor binding: Structure-activity analysis generates extremely potent xanthine antagonists. Proc. Natl. Acad. Sci. U.S.A. 80: 2077-2080, 1983.
7. BRUNS, R. F. AND FERGUS, J. H.: Solubilities of adenosine antagonists determined by radioreceptor assay. J. Pharm. Pharmacol. 41: 590-594, 1989.
8. 1-selective adenosine antagonist 8-cyclopentyl-1,3-dipropylxanthine to rat brain membranes. Naunyn-Schmiedeb. Arch. Pharmacol. 335: 59-63, 1987.
9. CULLEN, B. R.: Use of eukaryotic expression technology in the functional analysis of cloned genes. Methods Enzymol. 152: 684-703, 1987.
10. 3 receptors mediate hypotension in the angiotensin II-supported circulation of the pithed rat. Br. J. Pharmacol. 109: 3-5, 1993.
11. 6-Endonorbornan-2-yl-9-methyladenine) in humans (Abstract) Drug Dev. Res. 31: 278, 1994.
12. HOVINEN, J., GLEMAREC, C., SANDSTROM, A., SUND, C. AND CHATTOPADHYA, J.: Spectroscopic, kinetic and semiempirical molecular orbital studies on 8-amino-, 8-methylamino- and 8-dimethylaminoadenosines. Tetrahedron Lett. 47: 4693-4708, 1991.
13. 6-sulfoalkyl derivatives of adenosine: Water-soluble and peripherally selective adenosine agonists. J. Med. Chem. 35: 4143-4149, 1992.
14. LINDEN, J., JACOBSON, M. A , HUTCHINS, C. AND WILLIAMS, M.: Adenosine receptors. In Handbook of Receptors and Channels: G-Protein Coupled Receptors, ed. by S. J. Peroutka, pp. 29-44, CRC Press, Boca Rotan, 1994.
15. 1 receptors. J. Med. Chem. 31: 745-751, 1988.
16. 3 adenosine receptor with widespread tissue distribution. Mol. Pharmacol. 44: 524-532, 1993.
17. 125I]iodophenyl)ethylamino]adenosine. Mol. Pharmacol. 47: 307-313, 1995.
18. 2b receptors in the guinea pig aorta. Eur. J. Pharmacol. 216: 235-242, 1992a.
19. 2 adenosine receptor subtypes. Eur. J. Pharmacol. 214: 199-205, 1992b.
20. 1-adenosine receptor antagonists (Abstract). Br. J. Pharmacol. 104: 121, 1991.
21. 1 adenosine receptors in guinea pig isolated atria. J. Pharmacol. Exp. Ther. 265: 201-206, 1993a
22. 2 adenosine receptors in the aorta and the coronary vessels from the guinea pig. J. Pharmacol. Exp. Ther. 265: 248-253, 1993b.
23. NAGASHIMA, S., MOORE, H. J., TRACY, C. M., SOLOMON, A. J., HEWETT-MEULMAN, J. L., COWLEY, S. M., WOOSLEY, R. L. AND BARBEY, J. T.: Dose ranging study of N-0861, a new selective receptor antagonist, in patients receiving adenosine (Abstract). Am. J. Cardiol. 23: 127a, 1994.
24. 1 antagonist. Drugs Future 18: 433-435, 1993.
25. 6-endonorbornan-2-yl-9-methyladenine, N-0861, on negative chronotropic and vasodilatory actions of adenosine in canine heart in vivo. Can. J. Physiol. Pharmacol. 70: 1450-1456, 1992.
26. 3 adenosine receptor. Proc. Natl. Acad. Sci. U.S.A. 90: 10365-10369, 1993.
27. 1 adenosine receptors. J. Med. Chem. 35: 924-930, 1992
28. 1 subtype-selective adenosine receptor antagonist in the guinea pig isolated heart. J. Pharmacol. Exp. Ther. 260: 1292-1299, 1992.
29. 1-adenosine antagonist in pigs: Pharmacological and therapeutic implications. Cardiovasc. Res. 28: 621-628, 1994.
30. STRUHL, K : Subcloning of DNA fragments. In Current Protocols in Molecular Biology, ed. by F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seldman, J. A Smith and K. Struhl, pp. 3.16.1-3.16.11, John Wiley & Sons, Inc., New York, 1994
31. 1 adenosine receptor cDNA. Brain Res. 16: 365-370, 1992.
32. 1 adenosine receptor antagonism of postdefibrillation cardiovascular depression: Evidence for an antiadrenergic role of endogenous adenosine. Cardiovasc. Res. 27: 129-133, 1993.
33. 3 adenosine receptor. Proc. Natl. Acad. Sci U.S.A 89: 7432-7436, 1992.